We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
(+12%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$68.6M |
| 2 |
argenx
ARGX
|
+$55M |
| 3 |
Sanofi
SNY
|
+$50.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$50.5M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$48.6M |
| 2 |
Keurig Dr Pepper
KDP
|
+$45.5M |
| 3 |
Incyte
INCY
|
+$45.2M |
| 4 |
UnitedHealth
UNH
|
+$37.3M |
| 5 |
Campbell Soup
CPB
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.97% |
| 2 | Consumer Staples | 5.35% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Technology | 3.86% |
| 5 | Communication Services | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLR
301
Allarity Therapeutics
ALLR
$21.8M
| – | – |
-435
| Closed | -$195K |
|
|
APLT
302
DELISTED
Applied Therapeutics
APLT
| – | – |
-3,400,000
| Closed | -$8.47M |
|
|
303
CALL
argenx
ARGX
$55B
| – | – |
-140,000
| Closed | -$68.8M |
|
304
Arqit Quantum
ARQQ
$394M
| – | – |
-119,200
| Closed | -$1.77M |
|
|
FRMM
305
Forum Markets
FRMM
$84.3M
| – | – |
-689
| Closed | -$80.2K |
|
306
AtriCure
ATRC
$2.06B
| – | – |
-27,928
| Closed | -$1.22M |
|
307
Alibaba
BABA
$307B
| – | – |
-120,000
| Closed | -$10.4M |
|
308
BigBear.ai
BBAI
$1.54B
| – | – |
-548,000
| Closed | -$827K |
|
309
BCE
BCE
$21.2B
| – | – |
-5,729
| Closed | -$219K |
|
310
BJs Wholesale Club
BJ
$12.4B
| – | – |
-8,906
| Closed | -$636K |
|
311
Bristol-Myers Squibb
BMY
$131B
| – | – |
-529,613
| Closed | -$30.7M |
|
312
Boyd Gaming
BYD
$6.07B
| – | – |
-4,273
| Closed | -$260K |
|
313
CareDx
CDNA
$2.38B
| – | – |
-2,036,000
| Closed | -$14.3M |
|
314
Celsius Holdings
CELH
$6.86B
| – | – |
-174,000
| Closed | -$9.95M |
|
315
Celularity
CELU
$20.5M
| – | – |
-470,000
| Closed | -$1.04M |
|
316
Cingulate
CING
$70.4M
| – | – |
-3,145
| Closed | -$535K |
|
|
CMPS
317
Compass Pathways
CMPS
$1.82B
| – | – |
-400,000
| Closed | -$2.96M |
|
|
318
Campbell Soup
CPB
$6.87B
| – | – |
-778,571
| Closed | -$32M |
|
319
Caesars Entertainment
CZR
$6.14B
| – | – |
-15,598
| Closed | -$723K |
|
320
Dare Bioscience
DARE
$21.3M
| – | – |
-539,167
| Closed | -$2.99M |
|
321
Dropbox
DBX
$8.12B
| – | – |
-20,501
| Closed | -$558K |
|
322
Delcath Systems
DCTH
$525M
| – | – |
-164,000
| Closed | -$664K |
|
323
Deckers Outdoor
DECK
$13.3B
| – | – |
-191,580
| Closed | -$16.4M |
|
324
Estee Lauder
EL
$31.8B
| – | – |
-139,809
| Closed | -$20.2M |
|
|
ELEV
325
DELISTED
Elevation Oncology
ELEV
| – | – |
-750,000
| Closed | -$497K |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
- Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
- Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
- Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
- Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
- Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
- Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.
Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.